NEW YORK, July 10 - Applied Biosystems said Tuesday that it expects its revenue from instrument sales in the fiscal fourth quarter of 2001 to drop 12 percent to $192 million compared with $217 million in the year-ago quarter.

The company blamed the current economic slowdown for the decrease as well as an instrument glut because its customers bought "record-high" numbers of its instruments in the prior fiscal year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.